These results suggest that vitD, even in a smoke-exposed environment, has the potential to produce antimicrobial peptides and other antimicrobial agents like NO via iNOS, and thereby possibly limit infections and slow down the progression of COPD. This evidence concerns the gene NOS2 and infection.